35 completed, 17 recruiting, 9 unknown, 6 terminated. 44 Not applicable, 11 Phase 2, 9 Phase 4, 5 Phase 1, 3 Phase 3.
Follow Schizo Affective Disorder: new trials by email Literature Review of Schizo Affective Disorder trials Research Report on Schizo Affective Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2 Motion Perception Task, Sine Wave Speech Task, Volatility Task - SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder | Not applicable | Not yet recruiting | Washington University School of Medicine | 325 | 2028-04-01 | 2026-10-23 |
| Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA Intervention via mobile application - Schizophrenia, Schizo Affective Disorder | Not applicable | Not yet recruiting | University of Pittsburgh | 44 | 2027-06-01 | 2026-09-16 |
| Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia Placebo, IL-23 - Schizophrenia, Schizo Affective Disorder | Phase 4 | Not yet recruiting | University of Maryland, Baltimore | 40 | 2026-09-01 | 2026-05-29 |
| REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health) Clubhouse Model of Psychosocial Rehabilitation for Serious Mental Illness, Usual Community-Based Mental Health Care - Schizophrenia, Schizo Affective Disorder | Not applicable | Recruiting | Case Western Reserve University | 30 | 2026-08-30 | 2026-08-17 |
| Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways transcranial direct current stimulation, Sham stimulation - SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder | Not applicable | Recruiting | Nathan Kline Institute for Psychiatric Research | 120 | 2026-02-01 | 2026-03-13 |
| Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder Group Therapy Program, semaglutide, Phentermine-Topiramate - Bipolar I Disorder, Bipolar II Disorder | Phase 4 | Recruiting | Mayo Clinic | 100 | 2026-01-19 | 2026-03-11 |
| Visual Perception in Schizophrenia EEG measure of visual processing - Schizophrenia Disorders, Bipolar Disorder | Not applicable | Recruiting | University of Rochester | 84 | 2025-11-03 | 2025-11-12 |
| SEEG-Guided DBS for Schizophrenia SEEG implantation, Deep brain stimulation - Schizophrenia Disorders, Schizo Affective Disorder | Not applicable | Recruiting | Ruijin Hospital | 46 | 2025-08-17 | 2026-06-26 |
| Exploring the Feasibility of Transcranial Ultrasound Stimulation in the Treatment of Schizophrenia Transcranial Ultrasound Stimulation - Schizo Affective Disorder | Not applicable | Recruiting | Far Eastern Memorial Hospital | 80 | 2025-06-01 | 2026-06-02 |
| Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis Adapted physical activity program involving connected bikes - Schizophrenia; Psychosis, Schizo Affective Disorder | Not applicable | Unknown | Centre Hospitalier St Anne | 40 | 2024-12-01 | 2024-10-16 |
| Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy Sigma-Stim, RUL LAP-ST (Low-Amplitude Pulse Seizure Therapy - Right Unilateral) - Suicidal Ideation, Major Depressive Disorder | Phase 2 / Phase 3 | Recruiting | Michigan State University | 30 | 2024-07-03 | 2026-08-12 |
| Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia Lumateperone, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 4 | Recruiting | University of Massachusetts, Worcester | 50 | 2024-04-02 | 2026-05-22 |
| Young Adults With Violent Behavior During Early Psychosis (Aim 2) adapted behavioral intervention - Schizophrenia, Schizo Affective Disorder | Not applicable | Completed | Columbia University | 12 | 2024-03-19 | 2026-10-05 |
| TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis No intervention (Observational Study) - Psychosis, Schizo Affective Disorder | Recruiting | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 250 | 2024-03-01 | 2026-07-21 | |
| Getting Out of the House: Using Behavioral Activation to Increase Community Participation Behavior Activation - Major Depressive Disorder, Schizo Affective Disorder | Not applicable | Active not recruiting | Temple University | 52 | 2024-02-15 | 2026-06-22 |
| Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia rTMS, Placebo - Catatonia, Schizophrenia | Not applicable | Unknown | Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev | 60 | 2023-11-01 | 2023-12-19 |
| iTBS to Enhance Social Cognition in People With Psychosis iTBS (Active), iTBS (Sham) - Schizophrenia, Schizo Affective Disorder | Not applicable | Recruiting | Northwell Health | 100 | 2023-10-30 | 2026-10-08 |
| Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia | Phase 4 | Completed | BioXcel Therapeutics Inc | 29 | 2023-10-02 | 2026-08-11 |
| iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders iTEST - Schizophrenia, Schizo Affective Disorder | Not applicable | Completed | University of California, San Diego | 69 | 2023-10-01 | 2026-03-18 |
| Accelerated rTMS for Psychomotor Slowing cTBS (continuous Theta Burst Stimulation) - Schizophrenia; Psychosis, Schizophrenia and Related Disorders | Not applicable | Terminated | University of Bern | 25 | 2023-09-22 | 2024-09-25 |
Showing 20 of 76. Sign in to see all of them.
Psychotic Disorders (76) · Schizophrenia (69) · Bipolar Disorder (21) · Depressive Disorder, Major (7) · Mental Disorders (5) · Hallucinations (3) · Psychomotor Agitation (3) · Depression (2) · Medication Adherence (2) · Schizophrenia Spectrum and Other Psychotic Disorders (2) · Schizophrenia, Paranoid (2) · Schizophrenia, Treatment-Resistant (2) · Affective Disorders, Psychotic (1) · Aggression (1) · Anxiety Disorders (1)
Schizophrenia Spectrum and Other Psychotic Disorders (74) · Mental Disorders (71) · Bipolar and Related Disorders (21) · Mood Disorders (21) · Behavior (13) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (12) · Nervous System Diseases (10) · Neurologic Manifestations (10) · Neurobehavioral Manifestations (9) · Behavioral Symptoms (7) · Depressive Disorder (7) · Aberrant Motor Behavior in Dementia (4) · Dyskinesias (3) · Health Behavior (3)
Transcranial Direct Current Stimulation (7) · Transcranial Magnetic Stimulation (4) · Dexmedetomidine (3) · Cognitive Remediation (2) · Cognitive Training (2) · Lorazepam (2) · Acetazolamide (1) · Amyloid (1) · Arginine (1) · Counseling (1) · Cromolyn Sodium (1) · Deep Brain Stimulation (1) · Diet (1) · Diet, Ketogenic (1) · Exercise (1)
University of Maryland, Baltimore (3) · University of Michigan (3) · University of Minnesota (3) · Beth Israel Deaconess Medical Center (2) · BioXcel Therapeutics Inc (2) · Case Western Reserve University (2) · Indiana University (2) · Johns Hopkins University (2) · Mclean Hospital (2) · New York State Psychiatric Institute (2) · Northwell Health (2) · Temple University (2) · University of California, San Diego (2) · University of Massachusetts, Worcester (2) · University of Washington (2)
United States (53) · Canada (3) · India (2) · Switzerland (2) · Taiwan (2) · Australia (1) · Belgium (1) · China (1) · Denmark (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Portugal (1) · Russia (1)
BioXcel MM, MD (2) · Cynthia Burton, PhD (2) · Agnieszka Kalinowski, MD PhD (1) · Alex Borochov, MD (1) · Amy Sun, MD PhD (1) · Andreas Bechdolf, Prof. Dr. (1) · Antigona Martinez, PhD (1) · Caroline Demro, PhD (1) · Daniel C Javitt, MD, PhD (1) · Dawn Velligan, PhD (1) · Deanna Barch, PhD (1) · Deanna L Kelly, Pharm.D., BCPP (1) · Deanna L Kelly, PharmD, BCPP (1) · Donald Goff, MD (1) · Dror Ben Zeev, PhD (1)
PMID 19785727, PMID 21334602, PMID 22710617, PMID 23522057, PMID 23817024, PMID 24037621, PMID 25273286, PMID 25979608, PMID 26160288, PMID 26200928, PMID 26494483, PMID 28406662, PMID 28740827, PMID 30260448, PMID 30326433, PMID 30627303, PMID 30704863, PMID 30921747, PMID 30924789, PMID 30953588, PMID 31811557, PMID 32340927, PMID 32458107, PMID 32790451, PMID 32799938, PMID 32977798, PMID 33769295, PMID 33861952, PMID 33878489, PMID 33894334, PMID 33914891, PMID 35086504, PMID 35128308, PMID 35237135, PMID 36002761, PMID 36173600, PMID 36198061, PMID 36222818, PMID 36418846, PMID 36548028, PMID 36711165, PMID 36931706, PMID 36958998, PMID 37150147, PMID 37293030, PMID 37690312, PMID 38084398, PMID 38616053, PMID 38740618, PMID 39117276
2019 (1), D43TW009114 (1), I01RX000180 (1), K23MH126312 (1), P50MH119569 (1), R01AG058671 (1), R01MH084840 (1), R01MH118634 (1), R01MH120589 (1), R01MH126000 (1), R01MH138939 (1), R21DA041163 (1), R21MH114700 (1), R21MH116258 (1), R21MH140245 (1)